Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Calcium and Vitamin D Most Effective for Treatment of Crohn's-related Bone Loss
Study shows that calcium and vitamin D treatment alone can improve bone mineral density (BMD) in Crohn's patients by 3 to 4 percent per year; addition of popular bone building drugs to calcium and vitamin D therapy to treat bone loss associated with Crohn's disease is not beneficial.
- Calcium and Vitamin D Most Effective for Treatment of Crohn's-related Bone Loss
Study shows that calcium and vitamin D treatment alone can improve bone mineral density (BMD) in Crohn's patients by 3 to 4 percent per year; addition of popular bone building drugs to calcium and vitamin D therapy to treat bone loss associated with Crohn's disease is not beneficial.
- U.S. Department of Defense University and Humanetics to Co-Develop Multiple Compounds
Focus of new agreement is to develop and commercialize nutritional supplements and drugs that show promise in supporting and protecting the immune system against challenges from exposure to radiation
- U.S. Department of Defense University and Humanetics to Co-Develop Multiple Compounds
Focus of new agreement is to develop and commercialize nutritional supplements and drugs that show promise in supporting and protecting the immune system against challenges from exposure to radiation
- Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort)
Researchers note that half of those given St. John's wort for six weeks in this randomised double blind, reference controlled trial, reported an improvement in their symptoms, versus one third of those who took Seroxat.
- Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort)
Researchers note that half of those given St. John's wort for six weeks in this randomised double blind, reference controlled trial, reported an improvement in their symptoms, versus one third of those who took Seroxat.
- Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort)
Researchers note that half of those given St. John's wort for six weeks in this randomised double blind, reference controlled trial, reported an improvement in their symptoms, versus one third of those who took Seroxat.
- Advitech Completes Recruitment For Second Clinical Study on Oral Treatment For Psoriasis
Eighty-four patients with mild to moderate psoriasis have been recruited; treatment phase is expected to be completed by the end of June and results should be made available in July.
- Advitech Completes Recruitment For Second Clinical Study on Oral Treatment For Psoriasis
Eighty-four patients with mild to moderate psoriasis have been recruited; treatment phase is expected to be completed by the end of June and results should be made available in July.
- Advitech Completes Recruitment For Second Clinical Study on Oral Treatment For Psoriasis
Eighty-four patients with mild to moderate psoriasis have been recruited; treatment phase is expected to be completed by the end of June and results should be made available in July.
- Advitech Completes Recruitment For Second Clinical Study on Oral Treatment For Psoriasis
Eighty-four patients with mild to moderate psoriasis have been recruited; treatment phase is expected to be completed by the end of June and results should be made available in July.
- New Chromium Supplementation Clinical Trial Initiated - First to Study Effects in Overweight Children with Type 1 Diabetes
Double-blind, randomized, placebo-controlled clinical trial to study the effects of chromium picolinate supplementation in overweight pediatric patients with poorly-controlled type 1 diabetes to be initiated at Childrens Hospital Los Angeles.
- New Chromium Supplementation Clinical Trial Initiated - First to Study Effects in Overweight Children with Type 1 Diabetes
Double-blind, randomized, placebo-controlled clinical trial to study the effects of chromium picolinate supplementation in overweight pediatric patients with poorly-controlled type 1 diabetes to be initiated at Childrens Hospital Los Angeles.
- New Chromium Supplementation Clinical Trial Initiated - First to Study Effects in Overweight Children with Type 1 Diabetes
Double-blind, randomized, placebo-controlled clinical trial to study the effects of chromium picolinate supplementation in overweight pediatric patients with poorly-controlled type 1 diabetes to be initiated at Childrens Hospital Los Angeles.
- New Chromium Supplementation Clinical Trial Initiated - First to Study Effects in Overweight Children with Type 1 Diabetes
Double-blind, randomized, placebo-controlled clinical trial to study the effects of chromium picolinate supplementation in overweight pediatric patients with poorly-controlled type 1 diabetes to be initiated at Childrens Hospital Los Angeles.
- New Chromium Supplementation Clinical Trial Initiated - First to Study Effects in Overweight Children with Type 1 Diabetes
Double-blind, randomized, placebo-controlled clinical trial to study the effects of chromium picolinate supplementation in overweight pediatric patients with poorly-controlled type 1 diabetes to be initiated at Childrens Hospital Los Angeles.
- St. John’s wort as Effective as Popular Prescription Anti-Depressant
Organization comments on study published Friday February 13th in British Medical Journal.
- St. John’s wort as Effective as Popular Prescription Anti-Depressant
Organization comments on study published Friday February 13th in British Medical Journal.
- 14-Center Study Confirms Effectiveness of Aller-7 in 545 People With Airborne Allergies
Multicenter clinical trial spanning three years and involving 545 patients in 14 clinical centers confirms the safety and efficacy of Aller-7(R) in people with allergic rhinitis.
- 14-Center Study Confirms Effectiveness of Aller-7 in 545 People With Airborne Allergies
Multicenter clinical trial spanning three years and involving 545 patients in 14 clinical centers confirms the safety and efficacy of Aller-7(R) in people with allergic rhinitis.
- 14-Center Study Confirms Effectiveness of Aller-7 in 545 People With Airborne Allergies
Multicenter clinical trial spanning three years and involving 545 patients in 14 clinical centers confirms the safety and efficacy of Aller-7(R) in people with allergic rhinitis.
- 14-Center Study Confirms Effectiveness of Aller-7 in 545 People With Airborne Allergies
Multicenter clinical trial spanning three years and involving 545 patients in 14 clinical centers confirms the safety and efficacy of Aller-7(R) in people with allergic rhinitis.
- Advitech and CHUL Research Center to Test XP-828L For the Treatment of Inflammatory Bowel Diseases
Advitech and CHUL Research Center, CHULRC (CHUQ) will carry out a research project to assess the potential of XP-828L, a purified milk protein fraction with a patented growth factor composition, for treatment of inflammatory bowel diseases.
- Advitech and CHUL Research Center to Test XP-828L For the Treatment of Inflammatory Bowel Diseases
Advitech and CHUL Research Center, CHULRC (CHUQ) will carry out a research project to assess the potential of XP-828L, a purified milk protein fraction with a patented growth factor composition, for treatment of inflammatory bowel diseases.
- Advitech and CHUL Research Center to Test XP-828L For the Treatment of Inflammatory Bowel Diseases
Advitech and CHUL Research Center, CHULRC (CHUQ) will carry out a research project to assess the potential of XP-828L, a purified milk protein fraction with a patented growth factor composition, for treatment of inflammatory bowel diseases.
- Advitech and CHUL Research Center to Test XP-828L For the Treatment of Inflammatory Bowel Diseases
Advitech and CHUL Research Center, CHULRC (CHUQ) will carry out a research project to assess the potential of XP-828L, a purified milk protein fraction with a patented growth factor composition, for treatment of inflammatory bowel diseases.
- Folic Acid May Prevent Hypertension in Addition to Reducing the Risk of Birth Defects
JAMA study shows that for younger women who consume at least 1000 micrograms of folic acid the incidence of hypertension is decrased by 46%.
- Folic Acid May Prevent Hypertension in Addition to Reducing the Risk of Birth Defects
JAMA study shows that for younger women who consume at least 1000 micrograms of folic acid the incidence of hypertension is decrased by 46%.
- Folic Acid May Prevent Hypertension in Addition to Reducing the Risk of Birth Defects
JAMA study shows that for younger women who consume at least 1000 micrograms of folic acid the incidence of hypertension is decrased by 46%.
- Folic Acid May Prevent Hypertension in Addition to Reducing the Risk of Birth Defects
JAMA study shows that for younger women who consume at least 1000 micrograms of folic acid the incidence of hypertension is decrased by 46%.
- Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas
Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life.
- Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas
Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life.
- Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas
Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life.
- Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas
Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life.
- Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas
Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life.
- Scientific Experts Meet to Discuss Safety and Benefits of Vitamin E
Group concluded that antioxidant supplements are safe and appear to confer a health benefit in certain individuals; Future research in well-defined populations with both clinical and biomarker end-points needs to be undertaken.
- Scientific Experts Meet to Discuss Safety and Benefits of Vitamin E
Group concluded that antioxidant supplements are safe and appear to confer a health benefit in certain individuals; Future research in well-defined populations with both clinical and biomarker end-points needs to be undertaken.
- Scientific Experts Meet to Discuss Safety and Benefits of Vitamin E
Group concluded that antioxidant supplements are safe and appear to confer a health benefit in certain individuals; Future research in well-defined populations with both clinical and biomarker end-points needs to be undertaken.
- Scientific Experts Meet to Discuss Safety and Benefits of Vitamin E
Group concluded that antioxidant supplements are safe and appear to confer a health benefit in certain individuals; Future research in well-defined populations with both clinical and biomarker end-points needs to be undertaken.
- Scientific Experts Meet to Discuss Safety and Benefits of Vitamin E
Group concluded that antioxidant supplements are safe and appear to confer a health benefit in certain individuals; Future research in well-defined populations with both clinical and biomarker end-points needs to be undertaken.
- Scientific Experts Meet to Discuss Safety and Benefits of Vitamin E
Group concluded that antioxidant supplements are safe and appear to confer a health benefit in certain individuals; Future research in well-defined populations with both clinical and biomarker end-points needs to be undertaken.
- COLD-fX(R) to be Studied as New Way to Protect Seniors from Influenza in Canadian Nursing Homes
Company announces partnership project
to investigate the potential use of COLD-fX(R) as a "standard of care" for the
prevention of upper respiratory infections in Canadian nursing homes.
- COLD-fX(R) to be Studied as New Way to Protect Seniors from Influenza in Canadian Nursing Homes
Company announces partnership project
to investigate the potential use of COLD-fX(R) as a "standard of care" for the
prevention of upper respiratory infections in Canadian nursing homes.
- COLD-fX(R) to be Studied as New Way to Protect Seniors from Influenza in Canadian Nursing Homes
Company announces partnership project
to investigate the potential use of COLD-fX(R) as a "standard of care" for the
prevention of upper respiratory infections in Canadian nursing homes.
- COLD-fX(R) to be Studied as New Way to Protect Seniors from Influenza in Canadian Nursing Homes
Company announces partnership project
to investigate the potential use of COLD-fX(R) as a "standard of care" for the
prevention of upper respiratory infections in Canadian nursing homes.
- New Study Shows GliSODin(R) Inhibits DNA Damage Due to Ischemia-reperfusion Induced Oxidative Stress
German researchers conclude that pretreatment with GliSODin inhibits oxidative DNA damage related to induced ischemia-reperfusion injury.
- New Study Shows GliSODin(R) Inhibits DNA Damage Due to Ischemia-reperfusion Induced Oxidative Stress
German researchers conclude that pretreatment with GliSODin inhibits oxidative DNA damage related to induced ischemia-reperfusion injury.
- New Study Shows GliSODin(R) Inhibits DNA Damage Due to Ischemia-reperfusion Induced Oxidative Stress
German researchers conclude that pretreatment with GliSODin inhibits oxidative DNA damage related to induced ischemia-reperfusion injury.
- New Study Shows GliSODin(R) Inhibits DNA Damage Due to Ischemia-reperfusion Induced Oxidative Stress
German researchers conclude that pretreatment with GliSODin inhibits oxidative DNA damage related to induced ischemia-reperfusion injury.
- Effect of Folate and Mecobalamin on Hip Fractures in Patients With Stroke
Study shows that folate and vitamin B12 reduce risk of hip fracture in elderly patients.
- Effect of Folate and Mecobalamin on Hip Fractures in Patients With Stroke
Study shows that folate and vitamin B12 reduce risk of hip fracture in elderly patients.
- Effect of Folate and Mecobalamin on Hip Fractures in Patients With Stroke
Study shows that folate and vitamin B12 reduce risk of hip fracture in elderly patients.
- Effect of Folate and Mecobalamin on Hip Fractures in Patients With Stroke
Study shows that folate and vitamin B12 reduce risk of hip fracture in elderly patients.
- Vitamin D Injections May Significantly Improve Survival in Dialysis Patients
Study to be published in the April Journal of the American Society of Nephrology, shows that 76% of those dialysis patients receiving any form of activated vitamin D were still alive at the end of a two-year period, compared with 59% of those not receiving the therapy; researchers suggest more studies.
- Vitamin D Injections May Significantly Improve Survival in Dialysis Patients
Study to be published in the April Journal of the American Society of Nephrology, shows that 76% of those dialysis patients receiving any form of activated vitamin D were still alive at the end of a two-year period, compared with 59% of those not receiving the therapy; researchers suggest more studies.
- Vitamin D Injections May Significantly Improve Survival in Dialysis Patients
Study to be published in the April Journal of the American Society of Nephrology, shows that 76% of those dialysis patients receiving any form of activated vitamin D were still alive at the end of a two-year period, compared with 59% of those not receiving the therapy; researchers suggest more studies.
- Vitamin D Injections May Significantly Improve Survival in Dialysis Patients
Study to be published in the April Journal of the American Society of Nephrology, shows that 76% of those dialysis patients receiving any form of activated vitamin D were still alive at the end of a two-year period, compared with 59% of those not receiving the therapy; researchers suggest more studies.
- Daily Supplement May Boost Birthweight of Babies In The Developing World
Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies.
- Daily Supplement May Boost Birthweight of Babies In The Developing World
Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies.
- Daily Supplement May Boost Birthweight of Babies In The Developing World
Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies.
- Daily Supplement May Boost Birthweight of Babies In The Developing World
Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies.
- Daily Supplement May Boost Birthweight of Babies In The Developing World
Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies.
- Daily Supplement May Boost Birthweight of Babies In The Developing World
Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies.
- Daily Supplement May Boost Birthweight of Babies In The Developing World
Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies.
- Sunflower Seed Oil Can Protect Low Birth Weight Babies From Infection
Massaging low birth weight babies with sunflower seed oil is a low cost intervention that can protect them from infections.
- Sunflower Seed Oil Can Protect Low Birth Weight Babies From Infection
Massaging low birth weight babies with sunflower seed oil is a low cost intervention that can protect them from infections.
- Sunflower Seed Oil Can Protect Low Birth Weight Babies From Infection
Massaging low birth weight babies with sunflower seed oil is a low cost intervention that can protect them from infections.
- Sunflower Seed Oil Can Protect Low Birth Weight Babies From Infection
Massaging low birth weight babies with sunflower seed oil is a low cost intervention that can protect them from infections.
- Sunflower Seed Oil Can Protect Low Birth Weight Babies From Infection
Massaging low birth weight babies with sunflower seed oil is a low cost intervention that can protect them from infections.
- Sunflower Seed Oil Can Protect Low Birth Weight Babies From Infection
Massaging low birth weight babies with sunflower seed oil is a low cost intervention that can protect them from infections.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
HUDSON, NY – Eileen Sheets, director of regulatory affairs at Bioforce USA, has announced new study results underscoring the efficacy of a certified organic saw palmetto formula, Prostasan, in addressing mild, moderate and severe benign prostatic hyperplasia (BPH), concluding that the saw palmetto formulation may be a useful daily dietary supplement for men concerned about maintaining prostate health.
The study was conducted in Switzerland from May 2003 through June 2004 by a network of medical doctors on their patients who were diagnosed the first time with BPH symptoms or men who had already exhibited BPH symptoms but had not sought prior consultation. The men took one capsule per day (320 mg saw palmetto extract) of Prostasan for eight weeks.
The efficacy of Prostasan during the eight-week study was analyzed in 364 men who exhibited mild, medium and severe BPH symptoms. These were measured by severity of symptoms according to the International Prostate Symptom Score (IPSS), as follows: mild symptoms had a calculated IPSS score from 0 to 7 points; medium symptoms were allocated 8 to 19 points, and severe symptoms had a calculated IPSS score from 20 to 35 points. A significant reduction in the severity of symptoms (i.e. efficacy) was observed in all three groups.
Men with mild BPH symptoms reported a 42 percent improvement of their symptoms after eight weeks. Men with medium BPH symptoms showed a 37.8 percent improvement in their symptoms at the end of the study. Prostasan supplementation was even successful in the patient group with severe BPH symptoms. In this group, 95 patients with severe BPH reported a 30 percent reduction in the severity of their symptoms at the end of the study.
“Benign prostatic hyperplasia is a highly uncomfortable condition for many men, and it drastically reduces not only their daily quality of life but has some psychological impact as well,” Sheets notes. “We are proud to offer a natural, certified organic dietary supplement that addresses these issues. Prostasan has been a part of a daily regimen for millions of men worldwide; and the repeat purchases of the product demonstrate its success in this health circumstance.”
Sheets further notes that recent reports of adverse weather affecting the bounty and quality of Florida saw palmetto crops has opened the door of opportunity for cheaper and ineffective products from overseas. She reassures retailers and consumers that, “The saw palmetto berries we use from Florida are certified organic by Florida Certified Organic Growers, and we are supplied with a harvest report that demonstrates the superior quality, and hence, efficacy of the berry raw material. Prostasan is the only saw palmetto berry supplement that is also carries VSBLO/Bio Suisse and OCIA International Processor/Trader Organic certifications and the product meets Kommission E monographs for standardization equivalent to 270 mg fatty acids – dosages used in groundbreaking studies demonstrating its use to support the prostate.” The wildcrafted organic saw palmetto berries used in Prostasan are gently air dried to retain some moisture and are shipped, still fresh, to Switzerland where they are made into supplements. “And, knowing that the berries are organic will give men a greater sense of confidence of purity; Prostasan is a one-per-day supplement that is taken for the long term to nourish the prostate,” Sheets adds.
Prostasan is offered in 30-softgels.
About Bioforce USA
Propelled by the knowledge that botanical-based products enhance both specific health goals and overall vitality, Bioforce USA has created long-term strategic alliances with venerable European manufacturers of product lines that have years of clinical research support for safety and efficacy, plus years of repeat consumer use. Bioforce USA has brought these lines, which include A. Vogel, Sanhelios, Herbatint and L’Erbolario exclusively to the United States for distribution through natural products and health food stores.
Contact: Eileen Sheets 800 641-7555 |